In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Justus LeinhosDepartment of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria.ORCID 0009-0006-0445-1986 Theodora MalliLaboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, 4010 Linz, Austria.ORCID 0000-0003-4244-7954 Anna GablerDepartment of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria.
Daniel NothdurfterDepartment of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria.ORCID 0009-0007-9690-2293 Andreas ReichingerDepartment of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria.ORCID 0000-0002-1319-9798 Stefan SchwarzLaboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, 4010 Linz, Austria.
Johann MandlDepartment of Internal Medicine IV for Hematology and Medical Oncology, Hospital Wels-Grieskirchen, 4600 Wels, Austria.
Georg SchreilDepartment of Internal Medicine II for Medical Oncology, State Hospital Pyhrn-Eisenwurzen, 4400 Steyr, Austria.
Alexander AndorferDepartment of Internal Medicine I for Hematology and Medical Oncology, Sisters of Charity Hospital Ried, 4910 Ried im Innkreis, Austria.
Hannes WindhagerDepartment of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria.
Karl J AichbergerDepartment of Internal Medicine, State Hospital Rohrbach, 4150 Rohrbach, Austria.
Florian PrimavesiDepartment of Surgery, Ordensklinikum Linz, 4010 Linz, Austria.
Holger RumpoldDepartment of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria.ORCID 0000-0002-4118-0111 Bernhard DoleschalDepartment of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, 4010 Linz, Austria.ORCID 0009-0004-4813-4435 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
genomic instability scorehomologous recombination deficiencypancreatic cancerplatinum chemotherapyprecision oncologypredictive biomarker
Identifiers
PMID42882093
PMCPMC13666186
What OpenQuestion holds
Textmetadata
Read underepoch 390